buck, there is validity to your post, but I have a nephew involved in pharma sales, and he tells me you are always way way ahead to be promoting ancillary protocols for a popular drug, and certainly it appears here we have the most prescribed medication on the planet and one that physicians are extremely comfortable with. Even when the generic equivalents become available the inclination of physicians to prescribe this protocol will be extremely strong imo. Certainly possible the window of opportunity will only last for a few years, but in the pharma world that is a significant window. GLTA
News 
Market Data 
Discover 
AI
